Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
Indias growing diabetic population and increased healthcare infrastructure continue to drive the demand for diabetes treatments like GLP-1 receptor agonists
If you're looking to enhance your nutritional routine, I definitely recommend checking out their line
Cell Discov 10, 77 (2024)
A later study led by Martin Friedrichsen, also in Diabetes, Obesity and Metabolism, confirmed similar effects with the 2.4 mg dose used for weight management, showing better "control of eating" scores and reduced cravings overall (Friedrichsen et al., 2021)
See my options Order lab testing Comprehensive bloodwork for a fuller picture of your hormones, metabolism, and more